The Future of Chronic Kidney Disease Treatment: Combination Therapy (Polypill) or Biomarker-Guided Personalized Intervention?

Chronic kidney disease (CKD) is a global health burden that affects close to one billion individuals. As many healthcare systems struggle to accommodate existing patients, CKD incidence and related costs are projected to continue rising. Based on a systematic search, this narrative review offers an...

Cijeli opis

Bibliografski detalji

Glavni autori:	Sajjad Biglari, Harald Mischak, Joachim Beige, Agnieszka Latosinska, Justyna Siwy, Mirosław Banasik
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2025-06-01
Serija:	Biomolecules
Teme:	chronic kidney disease therapeutic interventions combination therapy personalized medicine biomarker-guided therapy treatment response prediction
Online pristup:	https://www.mdpi.com/2218-273X/15/6/809
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!